Maintain BUY with a TP of Rs 182 (1.3x Mar-20 ABV of Rs 140). Despite yet another setback, BOBs pedigreed leadership, its focus on quality growth and a relatively stronger B/S vs. peers (CRAR at 12.2%) keep us constructive. A strong asset quality pullback is likely as the accelerated recognition cycle abates (Slippages to fall from ~6% to 2% by FY20E). Clarity on the CEOs extension will be keenly awaited.